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Psychedelics exert unique effects on human consciousness. The
thalamic filter model suggests that core effects of psychedelics
may result from gating deficits, based on a disintegration of
information processing within cortico–striato–thalamo-cortical
(CSTC) feedback loops. To test this hypothesis, we characterized
changes in directed (effective) connectivity between selected CTSC
regions after acute administration of lysergic acid diethylamide
(LSD), and after pretreatment with Ketanserin (a selective serotonin
2A receptor antagonist) plus LSD in a double-blind, randomized,
placebo-controlled, cross-over study in 25 healthy participants. We
used spectral dynamic causal modeling (DCM) for resting-state fMRI
data. Fully connected DCM models were specified for each treat-
ment condition to investigate the connectivity between the follow-
ing areas: thalamus, ventral striatum, posterior cingulate cortex, and
temporal cortex. Our results confirm major predictions proposed in
the CSTC model and provide evidence that LSD alters effective con-
nectivity within CSTC pathways that have been implicated in the
gating of sensory and sensorimotor information to the cortex. In
particular, LSD increased effective connectivity from the thalamus to
the posterior cingulate cortex in a way that depended on serotonin
2A receptor activation, and decreased effective connectivity from
the ventral striatum to the thalamus independently of serotonin
2A receptor activation. Together, these results advance our mecha-
nistic understanding of the action of psychedelics in health and
disease. This is important for the development of new pharmacolog-
ical therapeutics and also increases our understanding of the mech-
anisms underlying the potential clinical efficacy of psychedelics.
serotonin | LSD | fMRI | effective connectivity | spectral dynamic
causal modeling
Classic hallucinogens or psychedelics induce an altered stateof consciousness characterized by alterations in mood, sen-
sory perception, thought, and the sense of self (1). Psychedelics,
therefore, offer the unique opportunity to investigate the neu-
ropharmacological and mechanistic underpinnings of perception,
thought, and consciousness. However, despite renewed scientific
and clinical interest in these substances, there are still major gaps
in our knowledge regarding the effects of psychedelics on the
brain and their pharmacological mechanism of action (2).
Geyer and Vollenweider (3) proposed that key effects of
psychedelics may result from gating deficits, based on the dis-
integration of information processing of internal and external
stimuli within cortico–striato–thalamo-cortical (CSTC) feedback
loops. This CSTC model suggests that the thalamus (Thal) plays
a key role in controlling or gating information to the cortex and
is thereby critically involved in the regulation of consciousness
(3). Alterations beyond the normal range of thalamic gating of
information are suggested to result in an overload of the cortex,
with excessive exteroceptive and interoceptive stimuli that may
ultimately cause the sensory flooding, cognitive disruptions, and
ego dissolution seen in both naturally occurring psychoses and
drug-induced altered states of consciousness (3, 4). This thalamic-
gating model is supported by results obtained in schizophrenia
patients showing increased functional and effective connectivity
between the thalamus and specific cortical brain regions (5, 6)
and studies showing deficits in preattentive sensorimotor gating
after the administration of psychedelics (7–9).
Thalamic gating has been suggested to be influenced by sev-
eral neurotransmitter systems. Blockade of NMDA receptors,
increase of dopaminergic neurotransmission, or excessive stim-
ulation of serotonin (5-HT) 2A receptors could lead to a neu-
rotransmitter imbalance within CSTC loops, which results in an
opening of the thalamic filter. The mesostriatal dopaminergic
and serotonergic projections provide input to the striatum and
are thought to be counterbalanced by the glutamatergic input
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derived from cortico–striatal pathways. Alterations in these neu-
rotransmitter systems may result in a diminished influence of the
striatum on the thalamus and open the thalamic filter (3, 4).
However, so far this model and its underlying pharmacology
have never been tested in humans. Pharmacological neuro-
imaging offers the opportunity to address these knowledge gaps
by investigating the influence of psychedelics on CSTC loops and
elucidating specific receptor contributions. Lysergic acid dieth-
ylamide (LSD) is a prototypical psychedelic drug with predom-
inantly agonist activity at 5-HT-2A/C, -1A/B, -6, and -7, and
dopamine D2 and D1 receptors (10). In this study, administra-
tion of LSD with and without pretreatment with the selective
5-HT2A receptor antagonist Ketanserin (Ket) offered the unique
opportunity to investigate the role of 5-HT2A receptor stimula-
tion by LSD in potentially altering the integration within and
between key constituents of CTSC system: the thalamus, the
ventral striatum (VS), the posterior cingulate cortex (PCC), and
the superior temporal gyrus. The PCC and the temporal cortex
(Temp) are two cortical areas that have repeatedly been iden-
tified to play a major role in psychedelic-induced altered states
of consciousness, in particular in alterations of self-experience
(11–14).
Furthermore, the present study capitalizes on recent advances
in modeling the endogenous brain activity, which underlies
resting-state fMRI data. We characterized each subject’s dis-
tributed neuronal dynamics using spectral dynamic causal mod-
eling (DCM) (15), which rests on a generative model of how
interacting neural populations cause fMRI time series, which in
turn give rise to functional connectivity measures (i.e., correlated
hemodynamic fluctuations) (Fig. 1). DCM provides estimates of
parameters quantifying the strength of directed connections be-
tween regions. We estimated these parameters at the between-
condition level using a Bayesian model (parametric empirical
Bayes, PEB) (16), enabling us to test for between-session (i.e.,
drug) effects. Compared with functional connectivity approaches,
which provide measures of correlation that cannot be used to
infer causality, spectral DCM quantifies (directed) effective
connectivity among brain regions. This aspect is crucial for
testing the thalamic-gating model, which predicts LSD-induced
increase in connectivity from the thalamus to cortical regions
and decreased connectivity from the VS to the thalamus.
This study, therefore, constitutes an investigation of fMRI
effective resting-state connectivity within the CTSC loops, its
alterations by LSD, and the underlying receptor pharmacology.
We hypothesized LSD-induced changes of effective connectivity
in accordance with the predictions of the thalamic-gating model.
Furthermore, we previously reported that psychedelic effects in
humans could be blocked by 5-HT2A receptor antagonism (17,
18). Therefore, we hypothesized that LSD-induced connectivity
changes are predominantly dependent on the 5-HT2A receptor.
Results
Subjective Drug Effects. Subjective drug effects were assessed us-
ing the 5-Dimensions Altered States of Consciousness (5D-ASC)
questionnaire (19). Detailed results are reported elsewhere (17).
In brief, all LSD-induced subjective drug effects were blocked by
Ket. No significant differences were found between the placebo
(Pla) and the Ket + LSD conditions (SI Appendix, Fig. S1).
Drugs vs. Placebo. The contrast drug vs. placebo [Pla < (LSD +
[Ket + LSD])] resulted in increased effective connectivity from
the thalamus to the VS and the PCC to the VS. Furthermore,
decreases in effective connectivity were found: from the thala-
mus to the Temp, the VS to thalamus, the VS to PCC, and the
VS to Temp. Regarding inhibitory self-connections, which con-
trol the regions’ gain or sensitivity to inputs, there was reduced
self-inhibition (i.e., disinhibition) of PCC due to the drug. These
results are shown in Fig. 2A.
5-HT2A Blockade. The contrast Ket + LSD < LSD revealed in-
creased effective connectivity from the thalamus to the VS and
PCC, and from the VS to the Temp. Decreased effective con-
nectivity was found from the PCC to the thalamus. Furthermore,
we found an increase in self-inhibition of the Temp. These re-
sults are shown in Fig. 2B.
An additional advantage of DCM is the possibility to deter-
mine the valence of the connections: that is, define whether they
are excitatory or inhibitory in nature. See Table 1 for the sum-
mary of the signed connectivity parameters and SI Appendix,
Table S1 for parameter estimates (mean and variance).
In sum, our analyses showed that LSD increased effective
connectivity from the thalamus to the PCC, whereas the reciprocal
connection from the PCC to the thalamus had reduced effective
connectivity. Furthermore, we also found decreased excitability
(i.e., increased self-inhibition) in the Temp. These alterations
seem to be driven by 5-HT2A receptor stimulation by LSD because
they were blocked by Ket. Furthermore, we found that LSD de-
creased effective connectivity from the VS to the thalamus and the
PCC, from the thalamus to the Temp, increased effective con-
nectivity from the PCC to the VS, and reduced self-inhibition of
the PCC. These LSD-induced changes were not blocked by Ket.
Discussion
Psychedelics induce an altered state of consciousness that, on the
one hand, mimics predominantly positive symptoms of schizo-
phrenia, but on the other hand, may have beneficial therapeutic
effects in mood and anxiety disorders (20). The history of re-
search on psychedelics is also intertwined with the investigation
of the role of the serotonergic system in cognition and behavior
in health and psychiatric disorders (3). However, the neurobi-
ology and pharmacology of psychedelics, in particular LSD, is
still poorly understood in humans. Geyer and Vollenweider (3)
Fig. 1. Four nodes of the DCM. The model includes the following nodes: VS,
Thal, Temp, and PCC. The associated time series were used to invert the
spectral DCM with a fully connected architecture.
Fig. 2. Connectivity changes for (A) Pla < [LSD + (LSD + Ket)] and (B) (LSD +
Ket) < LSD. n = 25.
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proposed that key effects of psychedelics may result from the
disintegration of information processing of internal and external
stimuli within CSTC feedback loops. In this work we sought to
mechanistically test this hypothesis by leveraging the recent ad-
vances in modeling endogenous activity using DCM for resting-
state fMRI (15) with the administration of LSD and Ket, a
5-HT2A receptor antagonist. Investigating effective (resting-
state) connectivity in LSD-induced states, the present study
closes critical knowledge gaps by showing that LSD alters con-
nectivity within CSTC pathways. In particular, LSD increases
effective connectivity from the thalamus to cortical areas, via
agonistic activity on the 5-HT2A receptor, and decreases effec-
tive connectivity from the VS to the thalamus independently of
5-HT2A receptor stimulation.
At the core of the CSTC model by Geyer and Vollenweider
(3) is the hypothesis that psychedelics alter the capacity of the
thalamus to control or gate the flow of information to the cortex.
The thalamus is the central part of the diencephalon containing
relay cells that project to the cortex (21). The thalamus also gates
the main input to the cortex from subcortical areas and likely
all regions of the cortex receive input from the thalamus (21). It
also plays a key role in various neurobiological theories of con-
sciousness, suggesting that neural activity in thalamo-cortical
loops gives rise to conscious experience (22, 23). During sleep,
sedation, and anesthesia, thalamo-cortical connectivity is de-
creased, while information transfer from the thalamus to the
cortex is highest during states requiring high levels of sustained
attention (24–29). Alterations in thalamo-cortical connectivity
are also crucial features of various psychiatric disorders, pre-
dominantly schizophrenia (6, 30–34), and also depression and
obsessive-compulsive disorder (35).
Here, we show that, in line with the CSTC model, LSD in-
creased the excitatory connection from the thalamus to the PCC.
This finding is particularly interesting in light of predictive cod-
ing formulations of the CSTC model, where filtering or gating is
implemented via changes in the precision of ascending pre-
diction errors. Much neurobiological evidence points to the
thalamus as a key source of the requisite neuromodulation (36).
This result is also consistent with a previous study showing in-
creased functional thalamo-cortical connectivity after LSD ad-
ministration (37). Furthermore, LSD increased excitability of the
PCC and reduced effective connectivity from the PCC to the
thalamus. The PCC has repeatedly been shown to be involved in
the effects of psychedelics. For example, decreased functional
connectivity between the PCC and frontal brain areas has been
reported after psilocybin and LSD administration (12, 14), as
well as decreased global brain connectivity after LSD adminis-
tration (38). Furthermore, at a postacute assessment 24 h after
ayahuasca intake, functional connectivity was increased be-
tween the PCC and the anterior cingulate cortex and reductions
in glutamate + glutamine, creatine, and N-acetylaspartate +
N-acetylaspartylglutamate in the PCC were measured (39). Our
study showing increased excitability of the PCC is also in line
with previous results reporting LSD, psilocybin, and ayahuasca-
induced decreases in α-power (13, 40–42), as decreases in
α-oscillations have been reported to reflect a state of enhanced
cortical excitability (43). Specifically, reductions in α-power in
the PCC assessed with magnetoencephalography after psilocybin
and LSD administration correlated with self-report question-
naire items indicating psilocybin-induced alterations in self-
processing and ego-integration (13). This is in line with current
theories of the role of the PCC in cognitive functioning, which
associate the PCC with arousal and awareness as well as the
control of the balance between internally and externally directed
thought (44). The interaction of the PCC with other brain net-
works is therefore considered to be important for conscious
awareness and the failure to suppress PCC activity to be asso-
ciated with the intrusion of internal mentation (44). Previous
effective connectivity studies using the spectral DCM have con-
sistently shown the PCC, which is a core region in the default
mode network (DMN), to be a robustly driven hub receiving
information from other core regions of the DMN: that is, the
medial prefrontal cortex and bilateral angular gyrus (45–47).
The CSTC model also proposes that the gating capacities of
the thalamus are controlled by the striatum (4). Vollenweider
and Geyer hypothesized that increasing serotonergic activation
by psychedelics reduces the influence of the striatum on the
thalamus, which leads to opening the thalamic filter. The present
data show that LSD indeed reduces effective connectivity from
the VS to the thalamus, therefore corroborating the assumption
that alterations in striatal–thalamic interaction are important
mechanisms underlying psychedelic states.
In contrast to LSD-induced increases in effective connectivity
from the thalamus to the PCC, excitatory connectivity from the
thalamus to the Temp was decreased and the inhibitory self-
connection of the Temp was increased by LSD. Previous studies
showed that: (i) decreases in functional connectivity between the
Temp and other cortical regions after LSD and psilocybin ad-
ministration (11, 12), and (ii) alterations in lagged phase syn-
chronization of δ-oscillations after psilocybin administration
(42), both correlating with subjective drug-induced effects. The
temporal lobe is associated with processing emotional and social
Table 1. Summary of results
Connection
Connectivity: ↑ = increased,
↓ = decreased
Valence: + = excitatory,
− = inhibitory
Effect size (typical effect
size is 0.1 Hz)
Contrast 1: Placebo < [LSD + (Ket + LSD)]
Thal → VS ↑ + 0.088
PCC → VS ↑ + 0.047
Thal → Temp ↓ + 0.275
VS → Thal ↓ + 0.184
VS → PCC ↓ + 0.139
VS → Temp ↓ − 0.325
PCC → PCC ↓ − 0.091
Contrast 2: (Ket + LSD) < LSD
Thal → VS ↑ + 0.143
Thal → PCC ↑ + 0.276
VS → Temp ↑ − 0.169
PCC → Thal ↓ − 0.098
Temp → Temp ↑ − 0.18
n = 25.
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information (48), both of which are altered in psychedelic states
(49–51) and is implicated in the pathophysiology of schizophre-
nia (52). Because it has been reported that patients suffering
from major depression disorder show increased thalamo-temporal
connectivity (53), attenuating effective connectivity from the
thalamus to the Temp might additionally represent a neurobio-
logical mechanism by which psychedelics potentially exert their
antidepressive potential (54). However, because the present
study investigated acute alterations in connectivity, further studies
are needed to clarify whether these results translate into long-term
therapeutic effects.
The present results therefore show that while the thalamus
indeed decreases information gating and therefore increases
“bottom-up” information flow to certain cortical areas as well as
the VS in accordance with the CSTC model, LSD does not cause
an undifferentiated cortical inundation as first hypothesized in
the model, but rather leads to a pattern of increased information
flow to particular areas of the cortex while thalamic connectivity
with other cortical areas is reduced in resting state. This might
explain the seemingly paradoxical subjective effects often reported
in psychedelic-induced altered states of consciousness that are
characterized by increased arousal as well as a dreamlike experi-
ence, impaired cognition but at the same time reported perceived
mental clarity, and psychosis-like effects combined with blissful
experiences (55). Therefore, psychedelics states differ from pre-
viously investigated states like anesthesia, sleep, or cognitively
demanding situations (24–28).
The design of the present study also involved the pretreatment
of LSD with the 5-HT2A receptor antagonist Ket and therefore
allowed for investigation of the role of this specific receptor
system in LSD-induced alterations in effective connectivity.
While we have previously shown that Ket blocked all subjective
and most neural effects of LSD (17, 38), the present analysis
showed particular alterations in the thalamus–PCC connections,
dependent on the 5-HT2A receptor. This is in line with a previous
study showing that PCC desynchronization under the influence
of psilocybin can be explained by increased excitability of 5-
HT2A receptor-rich deep-layer pyramidal neurons (13). In our
study, Ket blocked increased effective connectivity from the
thalamus to the PCC and reduced connectivity from the PCC to
the thalamus, as well as increased inhibition of the Temp. On the
other hand, mostly connections involving the VS were not
blocked by Ket: decreased effective connectivity from the VS to
the thalamus and the PCC, from the thalamus to the Temp, in-
creased effective connectivity from the PCC to the VS, and re-
duced inhibition of the PCC, suggesting that these LSD-induced
alterations are probably not attributable to LSD’s agonistic action
on the 5-HT2A receptor. Previous animal studies suggested that, in
addition to, 5-HT2A receptors, dopamine D2 receptors play a role
in the effects of LSD (56, 57). Considering that the effects not
blocked by Ket mostly involve the VS and that the striatum is a key
structure in dopaminergic pathways, the involvement of the do-
pamine system in LSD-induced alterations in brain connectivity
seems likely. However, the present study cannot conclusively an-
swer questions regarding the role of other receptor systems beyond
the 5-HT2A system in the neurobiological effects of LSD, and
therefore further studies are warranted to test the specific con-
tributions of other receptors, for example, by pretreatment with
dopamine-antagonists. However, considering that Ket normalized
all subjective effects, it is, on the one hand, possible that alter-
ations induced by LSD’s action on other receptors only provoke
noticeable subjective effects when 5-HT2A receptors are stimu-
lated concurrently. On the other hand, it is possible that higher
doses of LSD are needed to produce noticeable subjective effects
even when the 5-HT2A receptor is blocked. Future studies could
therefore test the effects of multiple (and higher) doses of LSD.
Beyond the CSTC model, several authors have proposed ad-
ditional theories to explain the biological underpinnings of
alterations in consciousness experienced following the adminis-
tration of psychedelics. An early psychophysiological model by
Fischer proposed that shifts in the ratio of sensory-to-motor
activity could explain subjective symptoms (58). More recent
evidence from human studies suggests that psychedelic-induced
alterations in consciousness are related to increased entropy in
the brain, leading to disorganization of brain activity and more
flexible cognition (entropic brain hypothesis) (59). This model
has been corroborated with studies showing that psilocybin
produces an increase in blood-oxygen level-dependent (BOLD)
signal variance and decreased connectivity within the DMN (60,
61). These models are not mutually exclusive, and focus on
complementary correlates of altered states of consciousness.
While this is beyond the scope of the present study, a unifying
framework should be developed and tested in future studies.
This study was limited to brain regions implicated by the
CSTC model, which have been shown empirically to be sensitive
to the effects of psychedelics in previous studies, as well as within
the current participants (3, 4, 11–14, 17, 62). Clearly, testing
additional models in future studies has the potential to extend
our knowledge about the effects of LSD on effective connectivity
among more distributed brain regions, in particular, additional
hubs of the CSTC model such as the medial prefrontal cortex.
Furthermore, future analyses using smaller regions-of-interest
(ROIs) could reveal differential effects of subregions of the
current ROIs. Additionally, to focus on drug effects using effi-
cient estimates of the cross-spectral density (CSD), we concat-
enated time-series data over subjects. This precluded analysis
between subject effects; for example, we were unable to relate
connectivity parameters to subjective effects. We will address
this limitation in the future using (hierarchical) PEB. Although a
previous study has shown that Ket does not induce an altered
state of consciousness or affect sensorimotor gating (8), the lack
of a Ket + Pla condition represents a further limitation of this
study. This suggests that future studies will be needed to char-
acterize the influence of Ket alone on effective connectivity.
In sum, the present results confirm major predictions pro-
posed in the CSTC model and provide evidence that LSD alters
effective connectivity within CSTC pathways that have been
implicated in the gating of sensory and sensorimotor information
to the cortex: LSD diminishes the influence of the striatum on
the thalamus and opens the thalamic filter, but selectively: only
to certain areas of the cortex. In particular, the present results
pinpoint the role of the thalamus–PCC connection for the effects
of psychedelics. Additionally, the present results enhance our
knowledge about the contribution of the serotonin system to the
functional organization of the brain in LSD-induced states. Fi-
nally, the present study showcases the newly developed spectral
DCM approach—coupled with modeling using the PEB frame-
work—to testing hypotheses in resting-state pharmacological
fMRI at the group level. Taken together, the results deepen our
knowledge about the mechanism of action of psychedelics rele-
vant for health and disease and important for the development
of new pharmacological therapeutics.
Methods
Participants. The data analyzed in this paper were collected as part of a larger
study, which is reported in refs. 17 and 38. The present characterization of
these data extends the analysis presented in Preller et al. (38). Participants
were recruited through advertisements placed in local universities. All par-
ticipants underwent a screening visit before inclusion in the study. All included
participants were healthy according to medical history, physical examination,
blood analysis, and electrocardiography. The Mini-International Neuropsy-
chiatric Interview (MINI-SCID) (63), the Diagnostic and Statistical Manual of
Mental Disorders, fourth edition self-rating questionnaire for Axis-II per-
sonality disorders (SCID-II) (64), and the Hopkins Symptom Checklist (SCL-90-R)
(65) were used to exclude subjects with present or previous psychiatric dis-
orders or a history of major psychiatric disorders in first-degree relatives.
Participants were asked to abstain from the use of any prescription or illicit
2746 | www.pnas.org/cgi/doi/10.1073/pnas.1815129116 Preller et al.
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drugs for a minimum of 2 wk before the first test day and for the duration of
the entire study, and to abstain from drinking alcohol for at least 24 h be-
fore test days. Urine tests and self-report questionnaires were used to verify
the absence of drug and alcohol use. Participants were required to abstain
from smoking for at least 60 min before MRI assessment and from drinking
caffeine during the test day. Urine tests were also used to exclude preg-
nancy. Further exclusion criteria included left-handedness, poor knowledge
of the German language, cardiovascular disease, history of head injury or
neurological disorder, history of alcohol or illicit drug dependence, MRI
exclusion criteria, including claustrophobia, and previous significant adverse
reactions to a hallucinogenic drug.
Twenty-five participants took part in the study (n = 19 males and 6
females; mean age = 25.24 y; SD = 3.72 y; range = 20–34 y). All participants
provided written informed consent statements in accordance with the
declaration of Helsinki before participation in the study. Subjects received
written and oral descriptions of the study procedures, as well as details
regarding the effects and possible risks of LSD and Ket treatment. The
Swiss Federal Office of Public Health, Bern, Switzerland, authorized the
use of LSD in humans, and the study was approved by the Cantonal Ethics
Committee of Zurich. The study was registered at ClinicalTrials.gov
(NCT02451072).
Study Design. In a double-blind, randomized, cross-over design, subjects re-
ceived either: (i) Pla + Pla condition: Pla (179 mg Mannitol and Aerosil 1 mg
orally) after pretreatment with Pla (179 mg Mannitol and Aerosil 1 mg
orally); (ii) Pla + LSD condition: LSD (100 μg orally) after pretreatment with
Pla (179 mg Mannitol and Aerosil 1 mg orally); or (iii) Ket + LSD (Ket + LSD)
condition: LSD (100 μg po) after pretreatment with the 5-HT2A antagonist
Ket (40 mg orally) at three different occasions 2 wk apart. Pretreatment with
Pla or Ket occurred 60 min before treatment with Pla or LSD to allow for Ket
to reach peak plasma levels (66). The resting-state scans (10 min) were ac-
quired twice: 75 min (session 1) and 300 min (session 2) after treatment
administration. The 5D-ASC (a retrospective self-report questionnaire) (19)
was administered to participants 720 min after drug treatment to assess
subjective experience after drug intake. Ninety-four items are answered on
visual analog scales. Scores were calculated for 11 validated scales (67): ex-
perience of unity, spiritual experience, blissful state, insightfulness, disembodi-
ment, impaired control and cognition, anxiety, complex imagery, elementary
imagery, audiovisual synesthesia, and changedmeaning of percepts. The 5D-ASC
score was analyzed using a repeated-measures ANOVA with drug condition
(Pla, LSD, and Ket + LSD) and scale as within-subject factors.
MRI Data Acquisition and Preprocessing. MRI data were acquired on a Philips
Achieva 3.0T whole-body scanner. A 32-channel receive head coil and
MultiTransmit parallel radio frequency transmission was used. Images were
acquired using a whole-brain gradient-echo planar imaging (EPI) sequence
(repetition time, 2,500 ms; echo time, 27 ms; slice thickness, 3 mm; 45 axial
slices; no slice gap; field of view, 240 × 240 mm2; in-plane resolution, 3 × 3 mm;
sensitivity-encoding reduction factor, 2.0). Additionally, high-resolution an-
atomical images (voxel size, 0.7 × 0.7 × 0.7 mm) were acquired using a
standard T1-weighted 3D magnetization prepared rapid-acquisition gradi-
ent echo sequence. The acquired images were analyzed using SPM12
(https://www.fil.ion.ucl.ac.uk). The preprocessing steps of the images con-
sisted of slice time correction, realignment, spatial normalization to the
standard EPI template of the Montreal Neurological Institute (MNI), and
spatial smoothing using a Gaussian kernel of 6-mm full-width half-
maximum. We investigated for any excessive head motion but head move-
ment did not exceed 3 mm in any participant.
ROI Selection and Time-Series Extraction. This study aims at investigating the
effect of LSD on the integrationwithin and between key constituents of CTSC
system. For this purpose, ROIs were identified as key nodes for effective
connectivity analysis, based on previous literature that considered: (i) the
thalamic gating model (3, 4); (ii) psychedelic-induced modulations of brain
activity and functional connectivity (11–14, 62) in independent participant
cohorts; and (iii) LSD-induced alterations in BOLD signal in the current co-
hort of participants, using (independent) task-based data (17, 18). The CTSC
loop was comprised of the thalamus, the VS, the PCC, and the temporal
gyrus. ROIs were masked by an 8-mm radius sphere centered on previously
reported MNI coordinates of these regions. These MIN coordinates were
derived from LSD-induced alterations in BOLD signal, in the same cohort of
participants, using task-based data (17, 18): thalamus: x = −15, y = −8, z = 1;
VS: x = 9, y = 8, z = −8; PCC: x = −3, y = −46, z = 31; Temp: x = −56, y = −54,
z = 8. These ROIs are shown in Fig. 1. Time series from the four ROIs were
corrected for head motion and physiological noise. For this purpose, the
nuisance regressors included the six head-motion parameters, cerebrospinal
fluid (extracted from left ventricle using a 4-mm sphere), and white matter
(extracted from pons using a 4-mm sphere) regressors. Low-frequency signal
drifts were filtered using a 128-s high-pass filter.
Dynamic Causal Modeling. The spectral DCM analyses were conducted using
DCM12 (revision 6759) implemented in the SPM12 (revision 12.2). In brief, we
concatenated the time series over subjects for each region, drug condition,
and session. This enabled us to focus on the difference between drug con-
ditions using more efficient estimates of the CSD. However, this precluded
analysis of between-subject effects, such as subjective effects. These estimates
were then taken to the between-condition level and modeled with two
orthogonal contrasts of condition-specific effects; namely, Pla vs. drug con-
ditions with and without Ket. This was repeated for both (early and late)
sessions. In detail, for each drug condition and session, a fully connected
model was created to compare all possible nested models of between- and
within-region interactions (16). DCM was estimated using spectral DCM,
which fits the complex cross-spectral density using a (parameterized) power-
law model of endogenous neuronal fluctuations (15, 47). For more details,
see the SI Appendix. This analysis provides measures of causal interactions
between regions, as well as the amplitude of endogenous neuronal fluctu-
ations within each region (47). Because the main effect of drug did not differ
between sessions, we focus on the first (early) session. To investigate the (i)
effect of drug and (ii) influence of the 5-HT2A blockade by Ket, the following
two orthogonal contrasts of effects (at the between-subject level) were
modeled: Pla < [LSD + (Ket + LSD)] and (Ket + LSD) < LSD. To report im-
portant effects, we used model comparisons (using free energy) with and
without each effect and then calculated the posterior probability for each
model, which is simply a softmax function of the log Bayes factor. We only
report effects (i.e., changes in directed connectivity) that have a posterior
probability >0.95 (SI Appendix, Table S1).
Data Availability. The extracted time series for each ROI and each condition, as
well as all statistics applied to these data, have been deposited in Bitbucket (68).
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